Abstract
Growth hormone (GH) induces lipolysis and an increase of free fatty acids (FFA), and FFA inhibit the GH response to arginine and to GH-releasing hormone (GHRH). The aim of this study was to evaluate the effect of the pharmacologic blockade of lipolysis on the GH response to GHRH. Eleven normal men underwent a saline infusion starting at 09:00 h, after administration of placebo or 500 mg acipimox, an antilipolytic agent; at 13:00 h (0 min) they received GHRH, 50 jig iv The GH response to GHRH (0 to 120 min) was significantly higher in subjects pretreated with acipimox than in subjects pretreated with placebo. In subjects receiving placebo, but not in those receiving acipimox, a progressive increase of plasma FFA levels took place, and the GH response to GHRH was inversely related to the plasma FFA levels at 0 min. These data indicate that FFA play an important role in the control of GH release, and that acipimox prevents the FFA rise induced by GH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dieguez C., Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. 28: 109, 1988.
Raben M.S., Hollenberg C.G. Effect of growth hormone on plasma fatty acids. J. Clin. Invest. 35: 484, 1959.
Fineberg S.E., Horland A.A., Merimee T.J. Free fatty acid concentrations and growth hormone secretion in man. Metabolism 27: 491, 1972.
Imaki T., Shibasaki T., Masuda A., Hotta M., Yamauchi N., Demura W., Shizume K., Wakabayashi I., Ling N. The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology 118: 2390, 1986.
Casanueva F.F., Villanueva L., Dieguez C., Diaz Y., Cabranes J.A., Szoke B., Scanlon M.F., Schally A.V., Fernandez - Cruz A. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J. Clin. Endocrinol. Metab. 65: 634, 1987.
Irie M., Sakuma M., Tsushima T., Shizume K., Nakao K. Effect of nicotinic acid administration on plasma growth hormone concentrations. Proc. Soc. Exp. Biol. Med. 126: 708, 1967.
Quabbe H.J., Bratzke H.J., Siegers U., Elban K. Studies on the relationship between plasma free fatty acids and growth hormone secretion in man. J.Clin. Invest. 57: 2388, 1972.
Pontiroli A.E., Viberti G.C., Pozza G. Growth hormone response to arginine in normal subjects and in patients with chemical diabetes and effect of clofibrate and of metergoline Proc. Soc. Exp. Biol. Med. 155: 160, 1977.
Rivier J., Spiess J., Thorner M., Vale W. Characterization of a growth hormone releasing factor from a human pancreatic islet tumor. Nature 300: 275, 1982.
Fuccella L., Goldaniga G., Lovisolo P. Inhibition of lipolysis by nicotinic acid and acipimox Clin. Pharmacol. Ther. 28: 790, 1980.
Stirling C., McAleer M., Reckless J.P.D., Campbell R.R., Mundy D., Betteridge D.J., Foster K. Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin. Sci. 68:83, 1985.
Hagen C., Brandt M.R., Kehlet M. Proclatin, LH, FSH, GH and Cortisol response to surgery and the effect of epidural analgesia. Acta Endocrinol. (Copenh.) 94: 151, 1980.
Page M.D., Koppesschaar P.F., Edwards C.A., Dieguez C., Scanlon M.F. Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man. Clin. Endocrinol. Oxf. 26: 589, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pontiroli, A.E., Lanzi, R., Monti, L.D. et al. Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects. J Endocrinol Invest 13, 539–542 (1990). https://doi.org/10.1007/BF03348621
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348621